Antiangiogenic effect of a Chinese sweet leaf tea extract in experimental corneal neovascularization

Pharmaceutical Biology

Volumn 45, Issue 1, 2007, Pages 44-47

  Oner, F Hakan ^a   Bezerra, Yanno ^a   Peyman, Gholam A ^a,f   Conway, Mandi D ^a   Lewis, James M ^b   Liu, Zhijun ^c   Greenway, Frank ^d   Woltering, Eugene A ^b,e  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Cornea; Leaf extract; Prevention; Silver nitrate

Indexed keywords

PLACEBO; PLANT EXTRACT; RUBUS SUAVISSIMUS EXTRACT; SILVER NITRATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUTERIZATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG SCREENING; HISTOPATHOLOGY; MALE; NONHUMAN; PHOTOGRAPHY; PLANT LEAF; RAT; STATISTICAL SIGNIFICANCE;

ANIMALIA; RATTUS; ROSACEAE; RUBUS;

EID: 34247347451     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200601026333     Document Type: Article

References (18)

1. Benelli U, Bocci G, Danesi R (1998): The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Exp Eye Res 67: 133-142.
2. Bocci G, Danesi R, Benelli U (1999): Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Canxer Chemother Pharmacol 43: 205-212.
3. Crum R, Szabo S, Folkman J (1985): A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375-1388.
4. Epstein RJ, Stulting RD, Hendricks RL, Harris DM (1987): Corneal neovascularization. Pathogenesis and inhibition. Cornea 6: 250-257.
5. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I (1988): A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130: 393-400.
6. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L (1995): Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125 (Suppl 3): 790S-797S.
7. Huang P-F, Jiang S-Q (2002): Comprehensive utilization of Rubus suavissimus S. Lee. Guangxi Huagong 31: 24-25.
8. Joussen AM, Kruse FE, Volcker HE, Kirchhof B (1999): Topical application of methotrexate for inhibition of corneal angiogenesis. Graefes Arch Clin Exp Ophthalmol 237: 920-927.
9. Joussen AM, Beecken WD, Moromizato Y, Schwartz A, Kirchhof B, Poulaki V (2001): Inhibition of inflammatory corneal angiogenesis by TNP-470. Invest Ophthalmol Vis Sci 42: 2510-2516.
10. Kotaro U (1997): Antiallergy action of Rubus suavissimus. Shokuhin Kogyo 40: 52-59.
11. Liu D, Gao Z, Zhang J, Ye J, Liu Z (2005): Bioassay-guided fractionation of the Rubus suavissimus leaf extracts possessing NF-κB inhibitory activities and a separable cytotoxicity. Pharm Biol 43: 713-717.
12. Liu Z, Schwimer J, Liu D, Lewis J, Greenway FL, York DA, Woltering EA (2006). Gallic acid is partially responsible for the anti-angiogenic activities of Rubus suavissimus leaf extract. Phytother Res 20: 806-813.
13. Mahoney JM, Waterbury LD (1985): Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res 4: 531-535.
14. Nakahara K (1998): Anti-allergic activity of Tiencha and oolong tea polyphenols. Food Style 21 (2): 45-49.
15. Nakahara K, Miyagawa K, Kodama T, Fujii W (1996): Anti-allergic composition containing GOD-type ellagitannin as active ingredient. Europe Patent No. 727218.
16. Ono Y (2002): The health beneficial effects of Tien-cha (Rubus suavissimus tea) and its applications. Food Style 21 (6): 77-80.
17. Suzuki T, Sano Y, Kinoshita S (2000): Effects of 1α,25- dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Invest Ophthalmol Vis Sci 41: 154-158.
18. Woltering EA, Watson JC, Alperin-Lea RC (1997): Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action. Invest New Drugs 15: 77-86.